Standard BioTools Inc. (LAB)
NASDAQ: LAB · IEX Real-Time Price · USD
2.540
-0.070 (-2.68%)
At close: Apr 18, 2024, 4:00 PM
2.530
-0.010 (-0.39%)
After-hours: Apr 18, 2024, 6:49 PM EDT
Standard BioTools Market Cap
Standard BioTools has a market cap or net worth of $972.94 million as of April 18, 2024. Its market cap has increased by 568.69% in one year.
Market Cap
972.94M
Enterprise Value
956.26M
1-Year Change
568.69%
Ranking
Category
Stock Price
$2.54
Market Cap Chart
Since February 10, 2011, Standard BioTools's market cap has increased from $260.60M to $972.94M, an increase of 273.35%. That is a compound annual growth rate of 10.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2024 | 757.20M | -3.69% |
| Apr 16, 2024 | 786.20M | -2.17% |
| Apr 15, 2024 | 803.60M | -0.72% |
| Apr 12, 2024 | 809.40M | -4.12% |
| Apr 11, 2024 | 844.20M | 2.46% |
| Apr 10, 2024 | 823.90M | -2.74% |
| Apr 9, 2024 | 847.10M | 1.39% |
| Apr 8, 2024 | 835.50M | 5.11% |
| Apr 5, 2024 | 794.90M | 3.39% |
| Apr 4, 2024 | 768.80M | -0.38% |
| Apr 3, 2024 | 771.70M | 0.76% |
| Apr 2, 2024 | 765.90M | -2.22% |
| Apr 1, 2024 | 783.30M | -0.37% |
| Mar 28, 2024 | 786.20M | 0.74% |
| Mar 27, 2024 | 780.40M | 1.89% |
| Mar 26, 2024 | 765.90M | -2.22% |
| Mar 25, 2024 | 783.30M | 0.75% |
| Mar 22, 2024 | 777.50M | -0.74% |
| Mar 21, 2024 | 783.30M | 3.05% |
| Mar 20, 2024 | 760.10M | 2.74% |
| Mar 19, 2024 | 739.80M | -1.54% |
| Mar 18, 2024 | 751.40M | -1.14% |
| Mar 15, 2024 | 760.10M | 1.94% |
| Mar 14, 2024 | 745.60M | -2.28% |
| Mar 13, 2024 | 763.00M | -1.86% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Centessa Pharmaceuticals | 1.04B |
| Belite Bio | 1.03B |
| Maravai LifeSciences Holdings | 1.01B |
| Silence Therapeutics | 1.01B |
| MacroGenics | 996.81M |
| Alignment Healthcare | 972.35M |
| Viridian Therapeutics | 951.56M |
| Abivax | 950.68M |